Current Radiopharmaceuticals

Editor-in-Chief

Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 2, August 2015



Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease) free to download

Volume:8   Issue: 2
Pp: 77-77
Furn F. (Russ) Knapp and Ambikalmajan M.R. Pillai
DOI: 10.2174/1874471008666150312124009
Published on: 12 March, 2015

Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

Volume:8   Issue: 2
Pp: 78-85
Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp
DOI: 10.2174/1874471008666150312155959
Published on: 12 March, 2015


Chemistry and bifunctional chelating agents for binding 177Lu

Volume:8   Issue: 2
Pp: 86-94
Józef L. Parus, Dariusz Pawlak, Renata Mikolajczak and Adriano Duatti
DOI: 10.2174/1874471008666150312160440
Published on: 12 March, 2015


Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176

Volume:8   Issue: 2
Pp: 95-106
Valery A. Tarasov, Oleg I. Andreev, Evgeny G. Romanov, Rostislav A. Kuznetsov, Vladimir V. Kupriyanov and Ivan V. Tselishchev
DOI: 10.2174/1874471008666150312160855
Published on: 12 March, 2015


Indirect Production of No Carrier Added (NCA) 177Lu from Irradiation of Enriched 176Yb: Options for Ytterbium/Lutetium Separation

Volume:8   Issue: 2
Pp: 107-118
Ashutosh Dash, Rubel Chakravarty, Furn F. (Russ) Knapp and Ambikalmajan M.R. Pillai
DOI: 10.2174/1874471008666150312161942
Published on: 12 March, 2015


Alternative method to determine Specific Activity of 177Lu by HPLC

Volume:8   Issue: 2
Pp: 119-122
Wouter A. P. Breeman, Rory M. S. de Zanger, Ho Sze Chan and Erik de Blois
DOI: 10.2174/1874471008666150312162340
Published on: 12 March, 2015


Estimation of specific activity of 177Lu by `saturation assay` principle using DOTA as ligand

Volume:8   Issue: 2
Pp: 123-128
Ambikalmajan M.R. Pillai, Sudipta Chakraborty and Tapas Das
DOI: 10.2174/1874471008666150312163720
Published on: 12 March, 2015


Accurate assessment of whole-body retention for PRRT with 177Lu using paired measurements with external detectors

Volume:8   Issue: 2
Pp: 129-138
Boxue Liu, Erik de Blois, Wouter A.P. Breeman, Mark W. Konijnenberg, Hubert T. Wolterbeek and Peter Bode
DOI: 10.2174/1874471008666150313110000
Published on: 13 March, 2015


Radiation Dosimetry Aspects of 177Lu

Volume:8   Issue: 2
Pp: 139-144
Michael Lassmann and Uta Eberlein
DOI: 10.2174/1874471008666150313104212
Published on: 12 March, 2015


Consequences of meta-stable 177mLu admixture in 177Lu for patient dosimetry

Volume:8   Issue: 2
Pp: 145-149
Mark W. Konijnenberg
DOI: 10.2174/1874471008666150313121315
Published on: 13 March, 2015


Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with 177Lu and Conjugated to Peptides

Volume:8   Issue: 2
Pp: 150-159
Guillermina Ferro-Flores, Blanca E. Ocampo-García, Clara L. Santos-Cuevas, Flor de María Ramírez, Erika P. Azorín-Vega and Laura Meléndez-Alafort
DOI: 10.2174/1874471008666150313115423
Published on: 13 March, 2015




Acknowledgements to Reviewers: free to download

Volume:8   Issue: 2
Pp: 160-160

DOI: 10.2174/187447100802150819121736
Published on: 19 August, 2015